These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18813860)

  • 1. Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
    Enjoji M; Kotoh K; Kato M; Higuchi N; Kohjima M; Nakashima M; Nakamuta M
    Int J Mol Med; 2008 Oct; 22(4):521-7. PubMed ID: 18813860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.
    Arao T; Okada Y; Mori H; Nishida K; Tanaka Y
    Endocr J; 2013; 60(5):563-70. PubMed ID: 23303198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?
    Georgescu EF
    Adv Ther; 2008 Nov; 25(11):1141-74. PubMed ID: 18972077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis.
    Georgescu EF; Ionescu R; Niculescu M; Mogoanta L; Vancica L
    World J Gastroenterol; 2009 Feb; 15(8):942-54. PubMed ID: 19248193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
    Nakayama S; Watada H; Mita T; Ikeda F; Shimizu T; Uchino H; Fujitani Y; Hirose T; Kawamori R
    Hypertens Res; 2008 Jan; 31(1):7-13. PubMed ID: 18360012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients.
    de Luis DA; Conde R; González-Sagrado M; Aller R; Izaola O; Dueñas A; Pérez Castrillón JL; Romero E
    Nutr Hosp; 2010; 25(2):275-9. PubMed ID: 20449538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
    Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
    Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
    Zhou WD; Yang YL; Che ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.
    Ichikawa Y
    Intern Med; 2007; 46(17):1331-6. PubMed ID: 17827829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.